SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000897069-01-500235
Filing Date
2001-06-01
Accepted
2001-06-01 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 pdm64a.txt 424B3 2021
  Complete submission text file 0000897069-01-500235.txt   3458
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT, QUEBEC CANADA, H4M 2V2 A8
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT, QUEBEC CANADA H4M 2V2 A8 514-332-32
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-31310 | Film No.: 1652411
SIC: 2835 In Vitro & In Vivo Diagnostic Substances